85 results
6-K
EX-99.5
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
in a different member country of the European Union, pursuant to article 16 of directive (EU) 2017/1132;
are being inserted by complete or proportional
6-K
EX-99.7
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
Reporting Standards, as adopted by the European Union (“IFRS”)) and which will be submitted to the AGM.4 The consolidated net equity of the Company
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
for the treatment of adults with moderate to severe UC in the European Union in 2021, and in Great Britain and Japan in January and March 2022 … , in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and with the legal and regulatory requirements applicable
6-K
EX-99.1
GLPG
Galapagos NV
6 Feb 24
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
6:00am
is currently approved for the treatment of moderate to severe active RA and UC by the relevant regulatory authorities in the European Union, Great
6-K
EX-99.1
g9witnyg64m0vhipoiu
4 Jan 24
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
4:05pm
6-K
EX-99.1
5c70f 6anbnvdv1dm
3 Nov 23
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
8:26am
6-K
EX-99.1
3c65s7p9 yp
2 Nov 23
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
7:15am
6-K
EX-99.2
ecrgb7xxczuams rbl
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.1
ji38uaos5e fz1teso
23 May 23
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
7:30am
6-K
EX-99.1
818jg 8aa0p9qi9sst
5 May 23
Galapagos announces first quarter 2023 financial results
4:05pm
6-K
EX-99.1
b3cfnd at9
2 May 23
Current report (foreign)
4:15pm
6-K
EX-99.1
im32vlnawob8w
23 Dec 22
Galapagos announces changes to Executive Committee
6:05am
6-K
EX-99.1
i798yszb
14 Nov 22
Current report (foreign)
6:05am
6-K
EX-99.1
yvqzj4
9 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
e2otblrvaddkwhjh
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
k65lyor1gk5lu5v
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
62f tjru2ydxjx7h0ral
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
uibzkypb xi68r3eww
17 Oct 22
Galapagos to host its R&D Update 2022 in New York on 4 November 2022
6:05am
6-K
EX-99.1
9thh5wz
6 Oct 22
Current report (foreign)
5:11pm